Positive impact of protease inhibitors on body composition and energy expenditure in HIV-infected and AIDS patients.
Schindler
K
K
Insitute of Nutritional Sciences, University of Vienna, Austria. karin.schindler@akh-wien.ac.at
Pernerstorfer-Schoen
H
H
Schneider
B
B
Rieger
A
A
Elmadfa
I
I
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight; D004032:Diet; D004359:Drug Therapy, Combination; D002149:Energy Intake; D004734:Energy Metabolism / Q000187:drug effects*; D005500:Follow-Up Studies; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D019888:Nelfinavir / Q000627:therapeutic use*; D015430:Weight Gain / Q000187:drug effects
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019888:Nelfinavir